-
Long-lasting opioid treatment recommended by an EMA committee
europeanpharmaceuticalreview
May 05, 2019
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
-
Cardiff Met develops new cancer treatment
europeanpharmaceuticalreview
April 30, 2019
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer…
-
New phase 3 data paints fuller picture for Horizon’s teprotumumab: AACE
fiercebiotech
April 29, 2019
On the back of a successful phase 3 study, Horizon Pharma said in February that its inflammatory eye drug was headed for an FDA filing midyear.
-
Fosmidomycin-piperaquine combination provides promising malaria treatment
europeanpharmaceuticalreview
April 29, 2019
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication…
-
Robotic implant aids the treatment of oesophageal atresia
europeanpharmaceuticalreview
April 29, 2019
Engineers have created a robot that can be used to help treat babies with a rare birth defect that affects an infant’s oesophagus…
-
Cannabidiol may help to reduce seizures in Lennox-Gastaut syndrome
europeanpharmaceuticalreview
April 29, 2019
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome…
-
Sodium benzoate enhances schizophrenia treatment
europeanpharmaceuticalreview
April 29, 2019
A randomised, double-blind, placebo-controlled trial has found that sodium benzoate improves symptoms in clozapine-resistant schizophrenia…
-
TSG12 provides a non-toxic therapeutic treatment for asthma
europeanpharmaceuticalreview
April 29, 2019
Researchers have identified a new treatment that could lead to more effective drug therapy for individuals with asthma and other respiratory disorders…
-
Biktarvy approved for the treatment of HIV-1 infection
europeanpharmaceuticalreview
April 29, 2019
Biktarvy approved for the treatment of HIV-1 infection
-
Delivering cancer treatment on a nanodisc helps eliminate tumours
europeanpharmaceuticalreview
April 25, 2019
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice…